Articles:

WA Colburn

Surrogate markers and clinical pharmacology
J Clin Pharmacol 1995 35: 441. [PDF]  

RW Piepho

Calcium antagonist use in congestive heart failure: still a bridge too far?
J Clin Pharmacol 1995 35: 443. [Abstract] [PDF]  

A Whelton

Renal effects of over-the-counter analgesics
J Clin Pharmacol 1995 35: 454. [Abstract] [PDF]  

JW Lee, JD Hulse, and WA Colburn

Surrogate biochemical markers: precise measurement for strategic drug and biologics development
J Clin Pharmacol 1995 35: 464. [Abstract] [PDF]  

D Babuty, B D'Hautefeuille, F Scheck, C Mycinsky, P Pruvost, and P Peraudeau

Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study
J Clin Pharmacol 1995 35: 471. [Abstract] [PDF]  

H Morita, K Hirabayashi, S Nozaki, K Ohmori, K Yoshikawa, and H Matsuo

Chronic effect of oral mexiletine administration on left ventricular contractility in patients with congestive heart failure: a study based on mitral regurgitant flow velocity measured by continuous-wave Doppler echocardiography
J Clin Pharmacol 1995 35: 478. [Abstract] [PDF]  

BF Johnson, GM Eisner, FG McMahon, AK Jain, P Rudd, and Sowers, JR

A multicenter comparison of adverse reaction profiles of isradipine and enalapril at equipotent doses in patients with essential hypertension
J Clin Pharmacol 1995 35: 484. [Abstract] [PDF]  

SK Gupta, RA Okerholm, M Eller, G Wei, CN Rolf, and J Gorsline

Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol
J Clin Pharmacol 1995 35: 493. [Abstract] [PDF]  

RF Kaiko, RP Grandy, RF Reder, PD Goldenheim, and RS Sackler

A bioequivalence study of oral controlled-release morphine using naltrexone blockade
J Clin Pharmacol 1995 35: 499. [Abstract] [PDF]  

MT Borin, MR Driver, and KK Forbes

Effect of timing of food on absorption of cefpodoxime proxetil
J Clin Pharmacol 1995 35: 505. [Abstract] [PDF]  

S Kishino, A Nomura, ZS Di, M Sugawara, K Iseki, S Kakinoki, A Kitabatake, and K Miyazaki

Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects
J Clin Pharmacol 1995 35: 510. [Abstract] [PDF]  

DD Christ

Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174
J Clin Pharmacol 1995 35: 515. [Abstract] [PDF]  

J Zhi, AT Melia, SG Koss-Twardy, B Min, R Guerciolini, NL Freundlich, G Milla, and IH Patel

The influence of orlistat on the pharmacokinetics and pharmacodynamics of glyburide in healthy volunteers
J Clin Pharmacol 1995 35: 521. [Abstract] [PDF]  

PA Reece, WR Garnett, Rock WL, Jr, Taylor, JR, B Underwood, AJ Sedman, and R Rajagopalan

Lack of effect of tacrine administration on the anticoagulant activity of warfarin
J Clin Pharmacol 1995 35: 526. [Abstract] [PDF]  

K Bachmann, TJ Sullivan, JH Reese, L Jauregui, K Miller, M Scott, KC Yeh, M Stepanavage, JD King, and J Schwartz

Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease
J Clin Pharmacol 1995 35: 529. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.